Pharmacokinetics and important drug-drug interactions to remember when treating advanced chronic kidney disease patients with hepatitis C direct acting anti-viral therapy-Reference-Cited by-同舟云学术

Pharmacokinetics and important drug-drug interactions to remember when treating advanced chronic kidney disease patients with hepatitis C direct acting anti-viral therapy

Published:2018-12-17 Issue:2 Volume:32 Page:141-151
ISSN:0894-0959
Container-title:Seminars in Dialysis
language:en
Short-container-title:Semin Dial

Author:

Cohen Elizabeth¹,Liapakis AnnMarie²

Affiliation:

1. Yale New Haven Transplantation Center; Yale University; New Haven Connecticut

2. Departments of Medicine and Surgery; Yale University; New Haven Connecticut

Publisher

Wiley

Subject

Nephrology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/sdi.12763/fullpdf

Reference54 articles.

1. Wolfe C Hep C+ into hep C- recipients

2. Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment;Gane;N Engl J Med,2017

3. Successful treatment of hepatitis C in renal transplant recipients with direct-acting antiviral agents;Sawinski;Am J Transplant,2016

4. Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation;Kamar;Am J Transplant,2015

5. Treatment with ledipasvir-sofosbuvir for 12 or 24 weeks in kidney transplant recipients with chronic hepatitis C virus genotype 1 or 4 infection: a randomized trial;Colombo;Ann Intern Med,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C;Physician Assistant Clinics;2021-10

2. Innovations in liver transplantation in 2020, position of the Belgian Liver Intestine Advisory Committee (BeLIAC);Acta Gastro Enterologica Belgica;2021-06

3. Potential interactions between pangenotypic direct-acting antivirals and concomitant cardiovascular therapies in patients with chronic hepatitis C virus infection;Journal of International Medical Research;2020-10

4. Position paper on the role of Internal Medicine in the management of hepatitis C virus infection (screening, diagnosis, linkage-to-care, treatment);Italian Journal of Medicine;2020-03-19

5. Verwendung HBV- oder HCV-infizierter Spenderorgane bei der Leber- und Nierentransplantation;Der Gastroenterologe;2019-05-17